Filing Flows › IDEX (IEX) › Q1 2026
IDEX (IEX) Q1 2026 earnings results (first quarter 2026)
10-Q filed Apr 29, 2026
IDEX (IEX) reported revenue of $887M for the first quarter 2026 (Q1 2026), +9% from a year earlier and -1% from the quarter before. Operating margin was 19.4%, net earnings $120M (13.5% of revenue).
IDEX, Q1 2026: revenue $887M (+9% year over year), operating margin 19.4%, net earnings $120M, operating cash flow $104M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $887M | -1% | +9% |
| Gross profit | $398M | +3% | +8% |
| Operating profit | $172M | -6% | +21% |
| Net earnings | $120M | -7% | +26% |
| Operating cash flow | $104M | -51% | -2% |
| Free cash flow | $86.0M | — | -6% |
What changed
Revenue was $886.9M in Q1 2026, up 9% year over year and down 1% from the previous quarter. Health & Science Technologies was the largest line at 45% of revenue. Health & Science Technologies added $57.3M year over year (up 17%), 79% of the total change.
Gross margin was 44.9%, down 0.4 points from Q1 2025. Operating profit was $172.4M, a 19.4% margin (up 2.0 points year over year). Of the extra revenue versus Q1 2025, 42% reached operating profit, above the 17% margin then. Operating expenses fell 1% while revenue rose 9%. Net earnings were $120.0M, up 26% year over year. The effective tax rate was 23.6%.
Operating cash flow was $103.7M (down 2% year over year), 86% of net earnings. Non-cash charges added back $53.7M of depreciation and amortization and $15.8M of share-based compensation. Working capital and other items used $85.7M. After capital expenditures ($17.7M), free cash flow as the company reports it was $86.0M.
Questions
What was IDEX's revenue in the first quarter 2026?
IDEX (IEX) reported revenue of $887M for the first quarter 2026 (Q1 2026), +9% from a year earlier and -1% from the quarter before.
Was IDEX profitable in the first quarter 2026?
Operating profit was $172M (19.4% of revenue) and net earnings $120M.
Source: IDEX 10-Q on SEC EDGAR.